A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

20046,320 citationsJournal Articlebronze Open Access

Authors

Soonmyung Paik · NSABP Foundation

Steven Shak

Gong Tang · University of Pittsburgh

Chungyeul Kim · NSABP Foundation

Joffre Baker · NSABP Foundation

Maureen Cronin

Frederick L. Baehner · University of California, San Francisco

Michael G. Walker

Abstract

The recurrence score has been validated as quantifying the likelihood of distant recurrence in tamoxifen-treated patients with node-negative, estrogen-receptor-positive breast cancer.

Topics & Keywords

Breast Cancer Treatment Studies HER2/EGFR in Cancer Research Estrogen and related hormone effects

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 351, Issue 27, pp. 2817-2826

DOI: 10.1056/nejmoa041588

Field-Weighted Citation Impact: 103.19